Proliferative Diabetic Retinopathy

Retina: Fourth Edition

Volumn 2-3, Issue , 2005, Pages 1285-1322

  Davis, Matthew D ^a   Blodi, Barbara A ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 72949098857     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-02598-0.50074-4     Document Type: Chapter

References (177)

1. Cogan D, Toussaint D, Kuwabara T Retinal vascular patterns. IV. Diabetic retinopathy. Arch Ophthalmol 1961, 66:366-378.
2. Davis M, Myers F, Engerman R, et al. Clinical observations concerning the pathogenesis of diabetic retinopathy. Symposium on the treatment of diabetic retinopathy. US Public Health Service publication no. 1890 1969, US Government Printing Office, Washington, DC. M. Goldberg, S. Fine (Eds.).
3. deVenecia G, Davis M, Engerman R Clinicopathologic correlations in diabetic retinopathy. I. Histology and fluorescein angiography of microaneurysms. Arch Ophthalmol 1976, 94:1766-1773.
4. Engerman R, Bloodworth JJ Experimental diabetic retinopathy in dogs. Arch Ophthalmol 1965, 73:205-210.
5. Kohner E, Henkind P Correlation of fluorescein angiogram and retinal digest in diabetic retinopathy. Am J Ophthalmol 1970, 69:403-414.
6. Muraoka K, Shimizu K Intraretinal neovascularization in diabetic retinopathy. Ophthalmology 1984, 91:1440-1446.
7. Ashton N Pathogenesis of diabetic retinopathy. Diabetic retinopathy 1983, Thieme-Stratton, New York. H. Little, R. Jack, A. Patz (Eds.).
8. Michelson I The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseases. Trans Ophthalmol Soc UK 1948, 68:137-180.
9. Shimizu K, Kobayashi Y, Muraoka K Midperipheral fundus involvement in diabetic retinopathy. Ophthalmology 1981, 88:601-612.
10. Wise G Retinal neovascularization. Trans Am Ophthalmol Soc 1956, 54:729-826.
11. Machemer R, Buettner H, Norton E, et al. Vitrectomy: a pars plana approach. Trans Am Acad Ophthalmol Otolaryngol 1971, 75:813-820.
12. Patz A Clinical and experimental studies on retinal neovascularization. Am J Ophthalmol 1982, 94:715-743.
13. Diabetic Retinopathy Study Research Group Photocoagulation treatment of proliferative diabetic retinopathy: the second report of the Diabetic Retinopathy Study findings. Ophthalmology 1978, 85:82-106.
14. Davis M Vitreous contraction in proliferative diabetic retinopathy. Arch Ophthalmol 1965, 74:741-751.
15. Taylor E, Dobree J Proliferative diabetic retinopathy: site and size of initial lesions. Br J Ophthalmol 1970, 54:11-18.
16. Diabetic Retinopathy Study Research Group Design, methods and baseline results, DRS report no 6. Invest Ophthalmol Vis Sci 1981, 21:149-209.
17. Davis M Methods of fundus examination. Vascular complications of diabetes mellitus 1967, Mosby, St Louis. S. Kimura, W. Caygill (Eds.).
18. Diabetic Retinopathy Study Research Group A modification of the Airlie House classification of diabetic retinopathy. DRS report no. 7. Invest Ophthalmol Vis Sci 1981, 21:210-226.
19. Prud'homme G, Rand L The Diabetic Retinopathy Study Research Group: distribution of maximum grade of lesions in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 1981, 20(suppl):59.
20. Schwartz J, Pavan P Optic disc edema. Int Ophthalmol Clin 1984, 24:83-91.
21. Kampik A, Kenyon K, Michels R, et al. Epiretinal and vitreous membranes: comparative study of 56 cases. Arch Ophthalmol 1981, 99:1445-1454.
22. Nork T, Wallow I, Sramek S, et al. Mueller's cell involvement in proliferative diabetic retinopathy. Arch Ophthalmol 1987, 105:1424-1429.
23. Davis M Natural history of diabetic retinopathy. Vascular complications of diabetes mellitus 1967, Mosby, St Louis. S. Kimura, W. Caygill (Eds.).
24. Dobree J Proliferative diabetic retinopathy: evolution of the retinal lesions. Br J Ophthalmol 1964, 48:637-649.
25. Bandello F, Gass J, Lattanzio R, et al. Spontaneous regression of neovascularization at the disk and elsewhere in diabetic retinopathy. Am J Ophthalmol 1996, 122:494-501.
26. Larsen H Diabetic retinopathy: an ophthalmoscopic study with a discussion of the morphologic changes and the pathogenetic factors in the disease. Acta Ophthalmol 1960, 60(Suppl.):1-89.
27. Tolentino F, Lee P, Schepens C Biomicroscopic study of vitreous cavity in diabetic retinopathy. Arch Ophthalmol 1966, 75:238-246.
28. Anderson BJ Activity and diabetic vitreous hemorrhages. Ophthalmology 1980, 87:173-175.
29. Tasman W Diabetic vitreous hemorrhage and its relationship to hypoglycemia. Mod Probl Ophthalmol 1979, 20:413-414.
30. Bresnick G, Haight B, deVenecia G Retinal wrinkling and macular heterotopia in diabetic retinopathy. Arch Ophthalmol 1979, 97:1890-1895.
31. Beetham W Visual prognosis of proliferating diabetic retinopathy. Br J Ophthalmol 1963, 47:611-619.
32. Ramsay W, Ramsay R, Purple R, et al. Involutional diabetic retinopathy. Am J Ophthalmol 1977, 84:851-858.
33. Caird F, Pirie A, Ramsell T Diabetes and the eye 1969, Blackwell Scientific, Oxford.
34. Polonsky K, Rubeinstein A C-peptide as a measure of the secretion and hepatic extraction of insulin: pitfalls and limitations. Diabetes 1984, 33:486-494.
35. Klein R, Davis M, Moss S, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: a comparison of retinopathy in younger and older onset diabetic persons. Comparison of type I and II diabetes 1985, Plenum Press, New York. M. Vranic, C. Hollenberg, G. Steiner (Eds.).
36. Diabetic Retinopathy Vitrectomy Study Research Group Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy: two-year results of a randomized clinical trial. Diabetic Retinopathy Vitrectomy Study report no 2. Arch Ophthalmol 1985, 103:1644-1652.
37. Aiello L, Rand L, Briones J, et al. Diabetic retinopathy in Joslin Clinic patients with adult onset diabetes. Ophthalmology 1981, 88:619-623.
38. Bodansky H, Cudworth S, Drury P, et al. Risk factors associated with severe proliferative retinopathy in insulin-dependent diabetes mellitus. Diabetes Care 1982, 5:97-100.
39. Dornan T, Mann JI, Turner R Factors protective against retinopathy in insulin-dependent diabetics free of retinopathy for 30 years. Br Med J 1982, 285:1073-1077.
40. Klein R, Klein B, Moss S, et al. Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA 1988, 260:2864-2871.
41. 1c) level. Diabetes 1985, 34:71.
42. Krolewski A, Warram J, Rand L, et al. Risk of proliferative diabetic retinopathy in juvenile-onset type I diabetes: a 40-year follow-up study. Diabetes Care 1986, 9:443-452.
43. Rand L, Krolewski A, Aiello L, et al. Multiple factors in the prediction of risk of proliferative diabetic retinopathy. N Engl J Med 1985, 313:1433-1438.
44. Beck-Nielsen H, Richelsen B, Mogensen CE, et al. Effect of insulin pump treatment for one year on renal function and retinal morphology in patients with IDDM. Diabetes Care 1985, 8:585-589.
45. Engerman R, Bloodworth JJ, Nelson S Relationship of microvascular disease in diabetes to metabolic control. Diabetes 1977, 26:760-769.
46. Engerman R, Kern T Progression of incipient diabetic retinopathy during good glycemic control. Diabetes 1987, 36:808-812.
47. Brinchmann-Hansen O, Dahl-Jorgensen K, Hannsen K, et al. The response of diabetic retinopathy to 41 months of multiple insulin injections, insulin pumps, and conventional insulin therapy. Arch Ophthalmol 1988, 106:1242-1246.
48. Knatterud GL, Klimt CR, Levin ME, et al. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatment. JAMA 1978, 240:37-42.
49. The Kroc Study patients at two years: a report on further retinal changes. Diabetes 1985, 34:39. Kroc Collaborative Study Group.
50. Lauritzen T, Frost-Larsen K, Larsen H, et al. Two-year experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy. Diabetes 1985, 34(Suppl.):74-79.
51. Reichard P, Berglund B, Britz A, et al. Intensified conventional insulin treatment retards microvascular complications of insulin-dependent diabetes mellitus (IDDM): The Stockholm Diabetes Intervention Study (SDIS) after 5 years. J Intern Med 1991, 230:101-108.
52. Stefansson E, Hatchell D, Fisher B, et al. Panretinal photocoagulation and retinal oxygenation in normal and diabetic cats. Am J Ophthalmol 1986, 101:657-664.
53. Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977. 936.
54. Diabetes Control and Complications Trial Research Group The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. Arch Ophthalmol 1995, 113:36-51.
55. Diabetes Control and Complications Trial Research Group Progression of retinopathy with intensive versus conventional treatment in diabetes control and complications trial. Ophthalmology 1995, 102:647-661.
56. lc) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 1996, 44:968-983.
57. Reichard P, Nilsson B, Rosenqvist U Retardation of the development of microvascular complications after long-term intensified insulin treatment: the Stockholm Diabetes Intervention Study. N Engl J Med 1993, 329:304-309.
58. Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen K, et al. Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin-dependent diabetes mellitus: the Oslo study. Br Med J 1985, 290:811-815.
59. Diabetes Control and Complications Trial Research Group Early worsening of diabetic retinopathy in the diabetes control and complications trial. Arch Ophthalmol 1998, 116:874-886.
60. Blood glucose control and the evolution of diabetic retinopathy and albuminuria: a preliminary multicenter trial. N Engl J Med 1984, 311:365-372. Kroc Collaborative Study Group.
61. Lauritzen T, Frost-Larsen K, Larsen H, et al. Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics. Lancet 1983, 1:200-204.
62. Lawson P, Champion M, Canny C, et al. Continuous subcutaneous insulin infusion (CSII) does not prevent progression of proliferative and pre-proliferative retinopathy. Br J Ophthalmol 1982, 66:762-766.
63. Puklin J, Tamborlane W, Felig P, et al. Influence of long-term insulin infusion pump treatment of type I diabetes on diabetic retinopathy. Ophthalmology 1982, 89:735-747.
64. Simmons R, Dueker D, Kimbrough R, et al. Goniophotocoagulation for neovascular glaucoma. Trans Am Acad Ophthalmol Otolaryngol 1977, 83:80-89.
65. Early Treatment of Diabetic Retinopathy Study Research Group (ETDRS) Manual of operations. National Technical Information Service PB85 223006/AS 1985, National Public Information Service, Washington, DC.
66. Early Treatment of Diabetic Retinopathy Study Research Group (ETDRS) Early treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report no. 7. Ophthalmology 1991, 98(Suppl. 5):741-756.
67. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with noninsulin-dependent diabetes mellitus: a randomized prospective 6-year study [see comments]. Diabetes Res Clin Pract 1995, 28:103-117.
68. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type2 diabetes (UKPDS 33). Lancet 1998, 352:837-853.
69. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000, 342:381-389.
70. Davis M, Fisher M, Gangnon R, et al. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment of Diabetic Retinopathy Study report no. 18. Invest Ophthalmol Vis Sci 1998, 39:233-252.
71. Verillo A, de Teresa A, Martino C, et al. Long-term improvement of metabolic control does not affect progression of background retinopathy. Transplant Proc 1986, 18:1569-1570.
72. Davis MD Diabetic retinopathy: a clinical overview [see comments]. Diabetes Care 1992, 15:1844-1874.
73. Chantelau E, Eggert H Acceleration of diabetic retinopathy following improved glycaemic control: a report on 13 cases. Diabetologia 1997, 40(Suppl. 1):501.
74. Chantelau E, Kohner E Why some cases of retinopathy worsen when diabetic control improves: worsening retinopathy is not a reason to withhold intensive insulin treatment. Br Med J 1997, 315:1105-1106.
75. Agardh CD, Eckert B, Agardh E Irreversible progression of severe retinopathy in young type I insulin-dependent diabetes mellitus patients after improved metabolic control. J Diabetes Complications 1992, 6:96-100.
76. Dandona P, Bolger J, Boag F, et al. Rapid development and progression of proliferative retinopathy after strict diabetic control. Br Med J 1985, 290:895-896.
77. Daneman D, Drash A, Lobes L, et al. Progressive retinopathy with improved control in diabetic dwarfism (Mauriac's syndrome). Diabetes Care 1981, 4:360-365.
78. Gudat U, Chantelau E Rapid-progressive diabetische Retino-pathie bei Stoffwechselmormalisierung: wer ist gefahrdet?. Z Klin Med 1992, 4:108-113.
79. Lawrence J, Bedford G, Thomson R Rapid development during puberty of proliferative retinopathy after strict diabetic control. Lancet 1985, 2:322.
80. Moskalets E, Galstyan G, Starostina E, et al. Association of blindness to intensification of glycemic control in insulin-dependent diabetes mellitus. J Diabetes Compl 1994, 8:45-50.
81. Henricsson M, Nilsson A, Janzon L, et al. The effect of glycaemic control and the introduction of insulin therapy on retinopathy in noninsulin-dependent diabetes mellitus [see comments]. Diabetes Med 1997, 14:123-131.
82. Roysarkar TK, Gupta A, Dash RJ, et al. Effect of insulin therapy on progression of retinopathy in noninsulin-dependent diabetes mellitus. Am J Ophthalmol 1993, 115:569-574.
83. Klein R, Klein B, Moss S Epidemiology of proliferative diabetic retinopathy. Diabetes Care 1992, 15:1875-1891.
84. Chew EY, Klein ML, Ferris FL, et al. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) report no. 22. Arch Ophthalmol 1996, 114:1079-1084.
85. Qiao Q, Keinanen-Kiukaanniemi S, Laara E The relationship between hemoglobin levels and diabetic retinopathy. J Clin Epidemiol 1997, 50:153-158.
86. Shorb SR Anemia and diabetic retinopathy. Am J Ophthalmol 1985, 100:434-436.
87. Berman DH, Friedman EA Partial absorption of hard exudates in patients with diabetic end-stage renal disease and severe anemia after treatment with erythropoietin. Retina 1994, 14:1-5.
88. Houssay B, Biasotti A La diabetes pancreatica de los perros hipofisoprivos. Rev Soc Argent Biol 1930, 6:251-296.
89. Luft R, Olivecrona H, Sjogren B Hypophysectomy in man. Nord Med 1952, 47:351-354.
90. Poulsen J The Houssay phenomenon in man: recovery from retinopathy in a case of diabetes with Simmonds' disease. Diabetes 1953, 2:7-12.
91. Poulsen J Diabetes and anterior pituitary insufficiency: final course and postmortem study of a diabetic patient with Sheehan's syndrome. Diabetes 1966, 15:73-77.
92. Kohner E, Joplin G, Blach R, et al. Pituitary ablation in the treatment of diabetic retinopathy. Trans Ophthalmol Soc UK 1972, 92:79-90.
93. Lundbaek K, Malmros R, Andersen H, et al. Hypophysectomy for diabetic retinopathy: a controlled clinical trial. Symposium on the treatment of diabetic retinopathy. US Public Health report no. 1890 1969, US Government Printing Office, Washington, DC. M. Goldberg, S. Fine (Eds.).
94. Panisset A, Kohner E, Cheng H, et al. Diabetic retinopathy: new vessels arising from the optic disc. II. Response to pituitary ablation by yttrium 90 implant. Diabetes 1971, 20:824-833.
95. Kohner E, Hamilton A, Joplin G, et al. Florid diabetic retinopathy and its response to treatment by photocoagulation or pituitary ablation. Diabetes 1976, 25:104-110.
96. Growth hormone antagonist for proliferative diabetic retinopathy study group The effect of a growth hormone receptor antagonist drug on proliferative diabetic retinopathy. Ophthalmology 2001, 108:2266-2272.
97. Aiello LP Clinical implications of vascular growth factors in proliferative retinopathies. Curr Opin Ophthalmol 1997, 8:19-31.
98. Casey R, Li WW Perspective: factors controlling ocular angiogenesis. Am J Ophthalmol 1997, 124:521-529.
99. Clermont A, Aiello L, Mori F, et al. Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of diabetic retinopathy. Am J Ophthalmol 1997, 124:433-446.
100. Frank RN Diabetic retinopathy. N Engl J Med 2004, 350:48-58.
101. Miller JW, Adamis AP, Aielli LP Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy. Diabetes Metab Rev 1997, 13:37-50.
102. Sönksen PH, Russell-Jones D, Jones RH Growth hormone and diabetes mellitus: a review of 63 years of medical research and a glimpse into the future?. Horm Res 1993, 40:68-79.
103. Meyer-Schwickerath G Light coagulation 1960, Mosby, St Louis.
104. Dobree J Light coagulation in proliferative diabetic retinopathy. Symposium on the treatment of diabetic retinopathy. US Public Health Service publication no. 1890 1969, US Government Printing Office, Washington, DC. M. Goldberg, S. Fine (Eds.).
105. Harris G, Rentiers P The role of photocoagulation in the therapy of proliferative diabetic retinopathy. Symposium on the treatment of diabetic retinopathy. US Public Health Service publication no. 1890 1969, US Government Printing Office, Washington, DC. M. Goldberg, S. Fine (Eds.).
106. Larsen H Photocoagulation in proliferative diabetic retinopathy: a preliminary report. Symposium on the treatment of diabetic retinopathy. US Public Health Service publication no. 1890 1969, US Government Printing Office, Washington, DC, . M. Goldberg, S. Fine (Eds.).
107. McMeel J, Van Hueven W Photocoagulation as a treatment of diabetic retinopathy. Symposium on the treatment of diabetic retinopathy. US Public Health Service publication no. 1890 1969, US Government Printing Office, Washington, DC. M. Goldberg, S. Fine (Eds.).
108. Okun E, Cibis P The role of photocoagulation in the therapy of proliferative diabetic retinopathy. Arch Ophthalmol 1966, 75:337-352.
109. Wetzig P, Jepson C Treatment of diabetic retinopathy by light coagulation. Am J Ophthalmol 1966, 62:459-465.
110. Wetzig P, Worlton J Treatment of diabetic retinopathy by light coagulation: a preliminary study. Br J Ophthalmol 1963, 47:539-541.
111. Beetham W, Aiello L, Balodimos M, et al. Ruby laser photocoagulation of early diabetic neovascular retinopathy: preliminary report of a long-term controlled study. Arch Ophthalmol 1970, 83:261-272.
112. Meyer-Schwickerath G, Schott K Diabetic retinopathy and photocoagulation. Am J Ophthalmol 1968, 66:597-603.
113. Okun E The effectiveness of photocoagulation in the therapy of proliferative diabetic retinopathy (PDR) (a controlled study in 50 patients). Trans Am Acad Ophthalmol Otolaryngol 1968, 72:246-252.
114. Aiello L, Beetham W, Balodimos M, et al. Ruby laser photocoagulation in treatment of diabetic proliferating retinopathy: preliminary report. Symposium on the treatment of diabetic retinopathy. US Public Health Service publication no. 1890 1969, US Government Printing Office, Washington, DC. M. Goldberg, S. Fine (Eds.).
115. Gerstein D, Dantzker D Retinal vascular changes in hereditary visual cell degeneration. Arch Ophthalmol 1969, 81:99-105.
116. Molnar J, Poitry S, Tsacopoulos M, et al. Effect of laser photocoagulation on oxygenation of the retina in miniature pigs. Invest Ophthalmol Vis Sci 1985, 26:1410-1414.
117. Weiter J, Zuckerman R The influence of the photoreceptor-RPE complex on the inner retina: an explanation for the benefit of special effects of photocoagulation. Ophthalmology 1980, 87:1133-1139.
118. Wolbarsht M, Landers MI The rationale of photocoagulation therapy for proliferative diabetic retinopathy: a review and a model. Ophthalm Surg 1980, 11:235-245.
119. Grunwald J, Riva C, Brucker A, et al. Altered retinal vascular response to 100% oxygen breathing in diabetes mellitus. Ophthalmology 1984, 91:1477. 1452.
120. Patel V, Rassam S, Newsom R, et al. Retinal blood flow in diabetic retinopathy. Br Med J 1992, 305:678-683.
121. Wilson D, Green W Argon laser panretinal photocoagulation for diabetic retinopathy: scanning electron microscopy of human choroidal vascular casts. Arch Ophthalmol 1987, 105:239-242.
122. Adamis AP, Shima DT, Yeo KT, et al. Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells. Biochem Biophys Res Commun 1993, 193:631-638.
123. Glaser B, Campochiaro P, Davis JJ, et al. Retinal pigment epithelial cells release an inhibitor of neovascularization. Arch Ophthalmol 1985, 103:1870-1875.
124. Ederer F, Hiller R Clinical trials, diabetic retinopathy, and photocoagulation: a reanalysis of five studies. Surv Ophthalmol 1975, 19:267-286.
125. Cheng H Multicentre trial of xenon-arc photocoagulation in the treatment of diabetic retinopathy: a randomized controlled study: interim report. Trans Ophthalmol Soc UK 1975, 95:351-357.
126. Aiello L, Berrocal J, Davis M, et al. The Diabetic Retinopathy Study. Arch Ophthalmol 1973, 90:347-348.
127. Diabetic Retinopathy Study Research Group Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol 1976, 81:383-396.
128. Diabetic Retinopathy Study Research Group Indications for photocoagulation treatment of diabetic retinopathy. DRS report no. 14. Int Ophthalmol Clin 1987, 27:239-253.
129. Diabetic Retinopathy Study Research Group Four risk factors for severe visual loss in diabetic retinopathy: the third report from the Diabetic Retinopathy Study. Arch Ophthalmol 1979, 97:654-655.
130. Diabetic Retinopathy Study Research Group Photocoagulation treatment of proliferative diabetic retinopathy: clinical application of Diabetic Retinopathy Study (DRS) findings. DRS report no. 8. Ophthalmology 1981, 88:583-600.
131. Diabetic Retinopathy Study Group Photocoagulation treatment of proliferative diabetic retinopathy: a short report on long-range results. DRS report no. 4. Proceedings of the Tenth Congress of the International Diabetes Foundation 1980, Excerpta Medica, Amsterdam. W. Waldhausl (Ed.).
132. Diabetic Retinopathy Study Research Group Photocoagulation of proliferative diabetic retinopathy: relationship of adverse treatment effects to retinopathy severity. DRS report no. 5. Dev Ophthalmol 1981, 2:248-261.
133. Rand L, Prud'homme G, Ederer F, et al. Factors influencing the development of visual loss in advanced diabetic retinopathy. Diabetic Retinopathy Study (DRS) report no. 10. Invest Ophthalmol Vis Sci 1985, 26:983-991.
134. British Multicentre Study Group Photocoagulation for proliferative diabetic retinopathy: a randomised controlled clinical trial using the xenon-arc. Diabetologia 1984, 26:109-115.
135. Hercules B, Gayed I, Lucas S, et al. Peripheral retinal ablation in the treatment of proliferative diabetic retinopathy: a three-year interim report of a randomised controlled study using the argon laser. Br J Ophthalmol 1977, 61:555-563.
136. Okun E, Johnston G, Boniuk I, et al. Xenon arc photocoagulation of proliferative diabetic retinopathy: a review of 2688 consecutive eyes in the format of the Diabetic Retinopathy Study. Ophthalmology 1984, 91:1458-1463.
137. Little H Proliferative diabetic retinopathy: pathogenesis and treatment. Diabetic retinopathy 1983, Thieme-Stratton, New York. H. Little, A. Patz, P. Forsham (Eds.).
138. Folk JC, Ma C, Blodi CF, et al. Occlusion of bridging or avulsed retinal vessels by repeated photocoagulation. Ophthalmology 1987, 94:1610-1613.
139. Early Treatment of Diabetic Retinopathy Study Group Case reports to accompany Early Treatment of Diabetic Retinopathy Study reports 3 and 4. Int Ophthalmol Clin 1987, 27:273-333.
140. Hilton G Panretinal cryotherapy for diabetic rubeosis. Arch Ophthalmol 1979, 97:776.
141. Little H, Rosenthal A, Dellaporta A, et al. The effect of panretinal photocoagulation on rubeosis iridis. Am J Ophthalmol 1976, 81:804-809.
142. May D, Bergstrom T, Parmet A, et al. Treatment of neovascular glaucoma with transscleral panretinal cryotherapy. Ophthalmology 1980, 87:1106-1111.
143. Murphy R, Egbert P Regression of iris neovascularization following panretinal photocoagulation. Arch Ophthalmol 1979, 97:700-702.
144. Pavan P, Folk J Anterior neovascularization. Int Ophthalmol Clin 1984, 24:61-70.
145. Pavan P, Folk J, Weingeist T, et al. Diabetic rubeosis and panretinal photocoagulation: a prospective, controlled, masked trial using iris fluorescein angiography. Arch Ophthalmol 1983, 101:882-884.
146. Bresnick GH, deVenecia G, Myers FL, et al. Retinal ischemia in diabetic retinopathy. Arch Ophthalmol 1975, 93:1300-1310.
147. Early Treatment of Diabetic Retinopathy Study Group Early photocoagulation for diabetic retinopathy. Early Treatment of Diabetic Retinopathy Study report no. 9. Ophthalmology 1991, 98:766-785.
148. Early Treatment of Diabetic Retinopathy Study Research Group Techniques for scatter and local photocoagulation treatment of diabetic retinopathy: the Early Treatment of Diabetic Retinopathy Study report no. 3. Int Ophthalmol Clin 1987, 27:254-264.
149. Ferris F Early photocoagulation in patients with either type I or type 2 diabetes. Trans Am Ophthalmol Soc 1996, 94:505-537.
150. KARNS Randomized comparison of krypton versus argon scatter photocoagulation for diabetic disc neovascularization. The Krypton Argon Regression Neovascularization Study report no. 1. Ophthalmology 1993, 100:1655-1664.
151. Meyer-Schwickerath G, Gerke E Treatment of diabetic retinopathy with photocoagulation: results of photocoagulation therapy of proliferative retinopathy in childhood-onset and maturity-onset and an approach to the dosage in photocoagulation. Acta Ophthalmol 1983, 61:756-768.
152. Chew E, Mills J, Metzger B, et al. Metabolic control and progression of retinopathy. The Diabetes in Early Pregnancy Study. Diabetes Care 1995, 18:631-667.
153. Klein B, Moss S, Klein R Effect of pregnancy on progression of diabetic retinopathy. Diabetes Care 1990, 13:34-40.
154. McDonald H, Schatz H Macular edema following panretinal photocoagulation. Retina 1985, 5:5-10.
155. McDonald H, Schatz H Visual loss following panretinal photocoagulation for proliferative diabetic retinopathy. Ophthalmology 1985, 92:388-393.
156. Meyers S Macular edema after scatter laser photocoagulation for proliferative diabetic retinopathy. Am J Ophthalmol 1980, 90:210-216.
157. Ferris FI, Podgor M, Davis M, et al. Macular edema in Diabetic Retinopathy Study patients. DRS report no. 12. Ophthalmology 1987, 94:754-760.
158. Blankenship G A clinical comparison of central and peripheral argon laser panretinal photocoagulation for proliferative diabetic retinopathy. Ophthalmology 1988, 95:170-177.
159. Shimura M, Yasuda K, Nakazawa T, et al. Quantifying alterations of macular thickness before and after panretinal photocoagulation in patients with severe diabetic retinopathy and good vision. Ophthalmology 2003, 110:2386-2394.
160. Liang H, Huamonte F Reduction of immediate complications after panretinal photocoagulation. Retina 1984, 4:166-170.
161. Doft B, Blankenship G Single versus multiple treatment sessions of argon laser panretinal photocoagulation for proliferative diabetic retinopathy. Ophthalmology 1982, 89:772-779.
162. Bandello F, Brancato R, Lattanzio R, et al. Double-frequency Nd:YAG laser vs. argon-green laser in the treatment of proliferative diabetic retinopathy: randomized study with long-term follow-up. Lasers Surg Med 1996, 19:173-176.
163. Bandello F, Brancato R, Trabucchi G, et al. Diode versus argon-green laser panretinal photocoagulation in proliferative diabetic retinopathy: a randomized study in 44 eyes with a long follow-up time. Graefes Arch Clin Exp Ophthalmol 1993, 231:491-494.
164. Doft B, Blankenship G Retinopathy risk factor regression after laser panretinal photocoagulation for proliferative diabetic retinopathy. Ophthalmology 1984, 91:1453-1457.
165. Vander JF, Duker JS, Benson WE, et al. Long-term stability and visual outcome after favorable initial response of proliferative diabetic retinopathy to panretinal photocoagulation. Ophthalmology 1991, 98:1575-1579.
166. Rogell G Incremental panretinal photocoagulation: results in treating proliferative diabetic retinopathy. Retina 1983, 3:308-311.
167. Reddy VM, Zamora RL, Olk RJ Quantitation of retinal ablation in proliferative diabetic retinopathy. Am J Ophthalmol 1995, 119:760-766.
168. Vine A The efficacy of additional argon laser photocoagulation for persistent, severe, proliferative diabetic retinopathy. Ophthalmology 1985, 92:1532-1537.
169. Blankenship G, Machemer R Prophylactic vitrectomy in proliferative diabetic retinopathy. Mod Probl Ophthalmol 1977, 18:236-241.
170. Diabetic Retinopathy Vitrectomy Study Research Group Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision: results of a randomized trial, Diabetic Retinopathy Vitrectomy Study report no. 3. Ophthalmology 1988, 95:1307-1320.
171. Diabetic Retinopathy Vitrectomy Study Research Group Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy: four-year results of a randomized trial. Diabetic Retinopathy Study report no. 5. Arch Ophthalmol 1990, 108:958-964.
172. deBustros S, Thompson J, Michels R, et al. Vitrectomy for progressive proliferative diabetic retinopathy. Arch Ophthalmol 1987, 105:196-199.
173. O'Hanley G, Canny C Diabetic dense premacular hemorrhage: a possible indication for prompt vitrectomy. Ophthalmology 1985, 92:507-511.
174. Ramsay R, Knobloch W, Cantrill H Timing of vitrectomy for active proliferative diabetic retinopathy. Ophthalmology 1986, 93:283-289.
175. Shea M Early vitrectomy in proliferative diabetic retinopathy. Arch Ophthalmol 1983, 101:1204-1205.
176. Diabetic Retinopathy Vitrectomy Study Research Group Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision: clinical application of results of a randomized trial. Diabetic Retinopathy Study report no. 4. Ophthalmology 1988, 95:1321-1334.
177. Shimura M, Yasuda K, Nakazawa T, et al. Quantifying alterations of macular thickness before and after panretinal photocoagulation in patients with severe diabetic retinopathy and good vision. Ophthalmology 2003, 110:2386-2394.